Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rechallenge”

78 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 78 results

Not applicableActive Not RecruitingNCT05571618
What this trial is testing

The Rechallenge of ADCs in MBC Patients

Who this might be right for
Breast Cancer
Fudan University 100
Not applicableStudy completedNCT01827254
What this trial is testing

Sutent Rechallenge In mRCC Patients

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 61
Testing effectiveness (Phase 2)Looking for participantsNCT06470971
What this trial is testing

Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial

Who this might be right for
Advanced Malignant Solid NeoplasmHematopoietic and Lymphatic System Neoplasm
Yuanquan Yang 40
Not applicableUnknownNCT03259009
What this trial is testing

RAS Mutations in ctDNA and Anti-EGFR reINTROduction in mCRC (RASINTRO)

Who this might be right for
Metastatic Colorectal Cancer
Association des Gastroentérologues Oncologues 73
Testing effectiveness (Phase 2)Study completedNCT03227926
What this trial is testing

Rechallenge With Panitumumab Driven by RAS Dynamic of Resistance

Who this might be right for
Colorectal Cancer
Fondazione del Piemonte per l'Oncologia 32
Testing effectiveness (Phase 2)Looking for participantsNCT06421298
What this trial is testing

A Prospective, Single-arm, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Tafolecimab and Sintilimab Combined With Chemotherapy in Patients With Advanced or Metastatic Driver Gene-negative Non-small Cell Lung Cancer After Failure of First-line Immunotherapy.

Who this might be right for
Lung Cancer
Jinghui Wang 30
Testing effectiveness (Phase 2)UnknownNCT05530200
What this trial is testing

PRaG Regimens Rechallenge for Patients With Resistance to PD1/PD-L1 Inhibitors in Refractory Advanced Solid Tumors.

Who this might be right for
Metastatic Solid Tumor
Second Affiliated Hospital of Soochow University 56
Testing effectiveness (Phase 2)UnknownNCT05325684
What this trial is testing

PD-L1 Inhibitor Rechallenge After PD-1 Immunotherapy for Patients With Solid Tumor Beyond Lung Cancer

Who this might be right for
EfficacySafety
The Affiliated Hospital of Qingdao University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07178717
What this trial is testing

Characterize Encorafenib Plus Cetuximab as Rechallenge Treatment for BRAF V600E-mutant Metastatic Colorectal Cancer Patients After Previous Therapy With BRAF Inhibitors-based Combinations

Who this might be right for
Colo-rectal Cancer
Vall d'Hebron Institute of Oncology 25
Large-scale testing (Phase 3)Study completedNCT01151852
What this trial is testing

Rechallenge of Imatinib in GIST Having no Effective Treatment: RIGHT

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 81
Early research (Phase 1)Not Yet RecruitingNCT06293339
What this trial is testing

Durability of Protection After Single Immunisation With GA2 Sporozoites (CoGA-Rechallenge)

Who this might be right for
Malaria,Falciparum
Leiden University Medical Center 14
Testing effectiveness (Phase 2)UnknownNCT02296203
What this trial is testing

Cetuximab Rechallenge in Irinotecan-pretreated mCRC, KRAS, NRAS and BRAF Wild-type Treated in 1st Line With Anti-EGFR Therapy (CRICKET).

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 27
Testing effectiveness (Phase 2)UnknownNCT05291156
What this trial is testing

CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy

Who this might be right for
Metastatic Colorectal Cancer
University of Campania Luigi Vanvitelli 173
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07836101
What this trial is testing

Study of Sarilumab With Immune Checkpoint Inhibitor Rechallenge in Patients With Clinically Significant Immune Related Adverse Events

Who this might be right for
Any Advanced Solid Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 41
Testing effectiveness (Phase 2)Study completedNCT04787341
What this trial is testing

PAnitumumab REchallenge Followed by REgorafenib Versus the Reverse Sequence

Who this might be right for
Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 213
Testing effectiveness (Phase 2)UnknownNCT03992456
What this trial is testing

Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal CarcinomaMetastatic Rectal Adenocarcinoma+27 more
Academic and Community Cancer Research United 12
Testing effectiveness (Phase 2)Looking for participantsNCT06663098
What this trial is testing

Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC).

Who this might be right for
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Gruppo Oncologico Italiano di Ricerca Clinica 142
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07699237
What this trial is testing

Phase II Trial to Evaluate Rechallenge With Platinum-based Chemotherapy (Carboplatin, Etoposide) for Progression During Tarlatamab Therapy in Relapsed Extensive Disease Small-cell Lung Cancer (SCLC)

Who this might be right for
Extensive Disease Small Cell Lung Cancer
University of Cologne 54
Testing effectiveness (Phase 2)UnknownNCT06362694
What this trial is testing

Study of the Rechallenge Concept in Patients With BRAF-positive Anaplastic Thyroid Cancer After Progression on Anti-BRAF Therapy

Who this might be right for
Anaplastic Thyroid Cancer
Saint Petersburg State University, Russia 10
Not applicableStudy completedNCT02192008
What this trial is testing

Investigating Enteric Fever - Salmonella Typhi and Paratyphi Challenge Study

Who this might be right for
Typhoid FeverParatyphoid Fever
University of Oxford 125
Next Page